Navigation Links
Celebrex- pros and cons

Though Celebrex reduces the possibility of growth of colon polyps to half, it doubles the risk of serious heart troubles.//

This was revealed by two significant studies published in the Aug. 31 issue of The New England Journal of Medicine. The opinions of Bruce M. Psaty, M.D., Ph.D., and John D. Potter, M.B., Ph.D., of the University of Washington were also published along with it.

"These two trials provide strong evidence that among patients with colonic adenomas, the use of celecoxib for up to three years reduces the risk of metachronous adenoma," Drs Bruce Psaty and John Potter.

"These placebo-controlled trials were too small to evaluate the role of celecoxib in preventing colorectal cancer. Nevertheless, in these same studies, significant cardiovascular risks were demonstrated. In patients with adenomas who undergo repeated colonoscopies, the increase in cardiovascular events caused by celecoxib outweighs what may be an optimistic projection of its potential benefit in decreasing colorectal-cancer events.”

Heart risks associated with Celebrex is being given a lot of importance by doctors. Celebrex belongs to the Cox-2 inhibitors, painkiller family. Vioxx and Bextra are the other members that are no longer available in the market due to their connection with heart disease.

Celebrex is not as dangerous as Vioxx. 200mgs a day is the common dosage of celebex. Though this dosage has never been associated with heart diseases or attacks, it does carry some risk when given along with all prescription anti-inflammatory drugs.Thus, FDA has necessitated a warning on the drug’s label.

Cox-2 inhibitors belong to the latest generation of the painkillers called NSAIDs (nonsteroidal anti-inflammatory drugs) whereas aspirin, ibuprofen, and naproxen are some of the older NSAIDs. The latter can cause stomach problems like ulcers. Cox-2 inhibitors are easier on the stomach than the older NSAIDs at low do sages.

Arthritis and other painful disorders are treated with Celebrex and other anti-inflammatory drugs. The patients with the help of their doctors should consider the advantages of these drugs against any likely risk. But for patients taking low doses of Celebrex for arthritis pain, it is more beneficial than harmful.

Celbrex has another function of preventing precancerous polyps in people with a rare condition called familial adenomatous polyposis. The risk of getting colon cancer is higher in this condition as there are more chances of polyps becoming cancerous. Celebrex, at a very high dose, is approved for the treatment.

But the advantages of Celebrex is overshadowed by the risk of heart problems in these people, because they are at a very high risk of colon cancer.
GA
'"/>




Related medicine news :

1. Simvastatin Plus Niacin May Lower Heart Risks
2. Ritalin May Lower Cocaine Abuse
3. Eating More Often May Help Lower Cholesterol
4. Lower surgical volume linked to higher death rate
5. Lowering blood pressure beneficial for PAD patients
6. Lower chance of bone fracture with Vitamin D supplementation
7. Tea Pill Lowers Cholesterol
8. Aspirin Lowers Leukemia Risk
9. Almonds Help Lower Cholesterol
10. Lowering Risk of Breast Cancer Recurrence
11. Drug to Lower Cholesterol Underused
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... has been recognized for adherence to the highest standards of trauma, maternity, ... organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among the ...
(Date:12/8/2016)... San Francisco, California (PRWEB) , ... December 08, 2016 , ... ... health coaches, has raised an $18M Series B led by Canvas Ventures . ... use the capital to scale its mobile platform to serve more consumers who are ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Pa. , Dec. 9, 2016 Department ... announced temporary regulations for medical marijuana dispensaries under Act ... Pennsylvania Bulletin , and are now available online ... is needed in the plan for operation; process for ... dispensary; as well as where the dispensary facilities can ...
(Date:12/8/2016)... Calif. , Dec. 8, 2016 IRIDEX Corporation ... to offer newly issued shares of common stock, $0.01 par ... to an underwritten public offering.  The final terms of the ... time of pricing, and there can be no assurance as ... IRIDEX expects to use the net proceeds it will ...
(Date:12/8/2016)... NEW YORK , Dec. 8, 2016 ... ... such as reducing loss of blood during surgeries, lowering the ... surgeries, and decreasing risks of SSIs. The patient warming systems ... and intravascular warming systems.These benefits in turn reduce the stay ...
Breaking Medicine Technology: